Insider plans 14,000-share Rule 144 sale at ZVRA

A shareholder of the issuer of ZVRA has filed a Rule 144 notice to sell 14,000 shares of common stock.

Accepted by SEC EDGAR 01/30/2026 - 04:20 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

A shareholder of the issuer of ZVRA has filed a Rule 144 notice to sell 14,000 shares of common stock. The planned sale, through Morgan Stanley Smith Barney LLC on the NASDAQ, has an aggregate market value of $124,040.00.

The 14,000 shares were acquired from the issuer as restricted stock units dated 01/30/2026, with the same date listed for payment. The notice also reports 56,297,535 shares of the issuer’s common stock outstanding and confirms the seller represents having no undisclosed material adverse information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for ZVRA disclose?

The Form 144 discloses a planned sale of 14,000 ZVRA common shares. The shares, valued at $124,040.00 in total, are to be sold on NASDAQ through Morgan Stanley Smith Barney LLC, under Rule 144 for resales of restricted or control securities.

How many ZVRA shares are planned to be sold under this Rule 144 notice?

The notice covers a planned sale of 14,000 shares of ZVRA common stock. These shares have an aggregate market value of $124,040.00 and are to be sold through Morgan Stanley Smith Barney LLC on the NASDAQ exchange, subject to Rule 144 conditions.

When are the ZVRA shares scheduled to be sold and on which exchange?

The planned sale date for the 14,000 ZVRA common shares is 01/30/2026. The securities are listed to be sold on the NASDAQ exchange, with Morgan Stanley Smith Barney LLC Executive Financial Services named as the broker handling the transaction.

How were the ZVRA shares in this Form 144 acquired?

The 14,000 ZVRA common shares were acquired on 01/30/2026 as restricted stock units from the issuer. The table lists the acquisition date and a corresponding date of payment of 01/30/2026, with the nature of payment indicated as “N/A” in the filing.

How many ZVRA shares are reported outstanding in this filing?

The Form 144 reports that 56,297,535 shares of the issuer’s common stock are outstanding. This figure provides context for the 14,000 shares covered by the planned Rule 144 sale, which represent only a small portion of the total outstanding shares.

What representation does the selling person make in the ZVRA Form 144?

By signing the notice, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, consistent with the standard representation language included in Rule 144 notice forms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001488774
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ZEVRA THERAPEUTICS INC
SEC File Number	001-36913
Address of Issuer	1180 Celebration Boulevard, Suite 103 Celebration FLORIDA 34747
Phone	3219393416
Name of Person for Whose Account the Securities are To Be Sold	R LaDuane Clifton
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Former CFO & Treasurer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	14000	124040.00	56297535	01/30/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/30/2026	Restricted Stock Units	Issuer			14000	01/30/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The securities to be sold were or will be acquired upon the vesting of restricted stock units during the period of 01/30/2026 through 01/31/2026.
Date of Notice	01/30/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/27/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ R LaDuane Clifton
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)